Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
100%
B Cell
45%
Rituximab
22%
CHOP
18%
Gene Expression Profiling
17%
Multiple Myeloma
16%
Biological Marker
14%
Malignant Neoplasm
13%
Neoplasm
13%
Personalized Medicine
12%
microRNA
11%
Diseases
10%
Acute Myeloid Leukemia
9%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
9%
Diagnosis
9%
Protein P53
9%
Vincristine
8%
Germinal Center B-Cell Like Diffuse Large B-Cell Lymphoma
8%
Gene Expression
8%
Melphalan
8%
Cancer
8%
Systematic Review
8%
Prevalence
8%
B-Cell Lymphoma
7%
Overall Survival
7%
Hematological Cancer
7%
International Prognostic Index
6%
Cancer Cell Line
6%
Germinal Center
6%
Follicular Lymphoma
6%
Cyclophosphamide
6%
T Cell
5%
Anaplastic Large Cell Lymphoma
5%
Targeted Therapy
5%
Prednisone
5%
microRNA 155
5%
Cancer Stem Cell
5%
Myeloma
5%
Stem Cell
5%
Immunology and Microbiology
B Cell
84%
Rituximab
18%
Gene Expression Profiling
10%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
10%
P53
8%
Germinal Center
8%
Gene Expression
8%
B Lymphocyte Subpopulation
8%
Multiple Myeloma
7%
Lymphoid Tissue
7%
Myeloid
7%
Gene Mutation
6%
Tonsil
6%
CXCR4
5%
Hemocyte
5%
Immune Response
5%
Cancer Stem Cell
5%
T Cell
5%
Exon
5%
Cyclophosphamide
5%
Keyphrases
Diffuse Large B-cell Lymphoma (DLBCL)
9%
Gene Expression Profile
5%
